← Back to Search
Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions
Hamilton, Canada
N/A
Waitlist Available
Led By Maureen Dobbins, RN, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 6-mo
Summary
Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by women facing breast cancer screening decisions.
Eligible Conditions
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 6-mo
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 6-mo
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Decisional Conflict Scale
Secondary study objectives
Decision quality
Preparation for Decision Making Scale
Screening behaviour
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental: Evidence + PDAExperimental Treatment2 Interventions
Evidence-based information on mammography such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources), plus a blog post on PDAs and the relevant decision aid from the Portal database
Group II: Evidence onlyExperimental Treatment1 Intervention
The same evidence-based information as group 1 (Evidence + PDA), but without the PDA to quantify the effect of accessing evidence through the Portal alone
Group III: Attention controlPlacebo Group1 Intervention
Information on how to distinguish high from low-quality health information, not specific to cancer screening or PDAs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Decision Aid
2020
N/A
~2740
Find a Location
Closest Location:McMaster University· Hamilton, Canada
Who is running the clinical trial?
McMaster UniversityLead Sponsor
932 Previous Clinical Trials
2,620,435 Total Patients Enrolled
13 Trials studying Breast Cancer
2,380 Patients Enrolled for Breast Cancer
Canadian Cancer Society (CCS)OTHER
82 Previous Clinical Trials
41,516 Total Patients Enrolled
6 Trials studying Breast Cancer
322 Patients Enrolled for Breast Cancer
Maureen Dobbins, RN, PhDPrincipal InvestigatorMcMaster University
3 Previous Clinical Trials
1,392 Total Patients Enrolled